The 6th Neuropsychiatric & Psychedelics Drug Development is dedicated to the latest scientific progress and current challenges in neuropsychiatric drug development.
6th Neuropsychiatric & Psychedelics Drug Development covers topics such as:
- Innovating clinical models to mitigate placebo & stratify patient populations
- A new era in neuropsychiatry: revolutionary pipeline advances
- Non-hallucinogenic psychoactive agents: reducing the safety risks of psychedelics
- Innovating clinical models to mitigate placebo & stratify patient populations
- Managing evolving regulatory guidelines & acceptance when entering a competitive neuropsychiatric market
- Recapitulating psychiatric conditions in preclinical model systems
- Exploring discovery technqiues & knowledge advances to identify more efficacous targets
The 6th Neuropsychiatric & Psychedelics Drug Development might be held in Massachusetts, United States in Sep 2024.
